People & Business :: M&A
Reckitt Benckiser to spin off pharmaceuticals business
9:00 AM MDT | July 28, 2014 | Natasha Alperowicz
Following a strategic review announced last October, Consumer goods group Reckitt Benckiser (RB; Slough, UK) said today that it plans to spin off its pharmaceuticals business. “We believe that RB Pharmaceuticals has the potential to deliver significant long-term value creation as a stand-alone business. We have therefore decided to pursue a demerger of RB Pharmaceuticals with a separate UK listing. We expect this to take place over the next 12 months. This will also allow RB to focus on its core strategy to be a global leader in consumer health...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee